Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
0.9786
-0.0314 (-3.11%)
At close: Jul 31, 2025, 4:00 PM
0.9800
+0.0014 (0.14%)
After-hours: Jul 31, 2025, 5:48 PM EDT
Lucid Diagnostics Market Cap
Lucid Diagnostics has a market cap or net worth of $105.67 million as of July 31, 2025. Its market cap has increased by 129.04% in one year.
Market Cap
105.67M
Enterprise Value
115.48M
1-Year Change
129.04%
Ranking
Category
Stock Price
$0.98
Market Cap Chart
Since the IPO on October 14, 2021, Lucid Diagnostics's market cap has decreased from $514.14M to $105.67M, a decrease of -79.45%. That is a compound annual growth rate of -34.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2025 | 109.28M | 140.74% |
| Dec 31, 2024 | 45.39M | -23.95% |
| Dec 29, 2023 | 59.69M | 12.22% |
| Dec 30, 2022 | 53.19M | -73.09% |
| Dec 31, 2021 | 197.66M | -61.55% |
| Oct 14, 2021 | 514.14M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.93B |
| Johnson & Johnson | 404.87B |
| AbbVie | 337.77B |
| Novo Nordisk | 238.11B |
| UnitedHealth Group | 236.83B |
| AstraZeneca | 230.79B |
| Novartis AG | 227.32B |
| Abbott Laboratories | 222.72B |